Skip to Main Content
Try STAT+ TODAY
Trending:
Health
Biotech
STAT+
Pharma
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Biotech
STAT+

University of California squares off against major publisher, with big stakes for access to research

  • Rebecca Robbins

By Rebecca Robbins Dec. 19, 2018

Reprints
Berkeley and Oakland
The University of California campus in Berkeley. Eric Risberg/AP

This story first appeared in “Go West,” STAT’s weekly newsletter about West Coast life sciences, health care, and biotech. Sign up here to receive it in your inbox. 

SAN FRANCISCO — There’s a high-stakes fight in California that could shape the way that academic research gets read and published far beyond the West Coast.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Rebecca Robbins

Rebecca Robbins

Health Tech Correspondent

Rebecca covers health technology. She is the co-author of the newsletter STAT Health Tech.

Tags

Gene therapy pioneer Kathy High leaves AskBio
Gene therapy pioneer Kathy High leaves AskBio
Chinese DNA giant’s U.S. affiliate looks to rival Illumina,…
Chinese DNA giant’s U.S. affiliate looks to rival Illumina, touting $100 genome and high-power sequencers
‘They were his best shot. And they failed to…
‘They were his best shot. And they failed to help’: Why did EMS workers neglect Tyre…
How one biotech investor is changing his calculus now…
How one biotech investor is changing his calculus now that Medicare can negotiate drug prices
Gene therapy pioneer Kathy High leaves AskBio
Gene therapy pioneer Kathy High leaves AskBio
New mouse study shows genes aren’t only way to…
New mouse study shows genes aren’t only way to pass obesity to next generation

Recommended Stories